Family-run Jani Sales: (L-r) Saifee Jani and son and Managing Director Abiali Jani

India’s Jani Sales has boosted its production capacity after investing in a paper machine.
TM3 will have a production capacity of 80tpd and is expected to come on stream in
May 2026.

Once up and running the family-run company’s total scheduled annual production capacity will increase to 82,000tpy, combining the strengths of its PM1 MG Machine, PM2 Tissue Machine, and new PM3 Tissue Machine.

Abiali Jani, Managing Director, Jani Sales, said: “This investment marks another significant milestone in our journey of innovation and excellence in paper manufacturing.

“It is a testament to our unwavering commitment to quality, technological advancement, and sustainable growth.”

PM3 will produce premium tissue products, which he said further reinforces the company’s position as a trusted global supplier.

“At Jani Sales, we believe in pushing boundaries and setting new benchmarks. PM3 is more than just a machine – it’s a symbol of our dedication to innovation and customer satisfaction.”

The company declined to announce the name of the machinery supplier at this time.